AARD
Aardvark Therapeutics, Inc.
5.00$
-5.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 98.4% | – | 99.8% | 98.7% | 95.7% | 98.4% | 98.2% | 97.0% | 95.5% | 94.9% | 99.0% | |
| – | 92.4% | – | 98.8% | 98.3% | 79.5% | 16.9% | 17.6% | 29.5% | 40.2% | 63.3% | 90.7% | |
| – | 94.8% | – | 99.0% | 98.4% | 95.0% | 96.3% | 96.2% | 94.8% | 93.9% | 92.5% | 90.7% | |
| – | 430.3% | – | 148.5% | 155.1% | 170.5% | 4.0% | 7.2% | 8.1% | 9.0% | 11.8% | 8.2% | |
| – | 13.1% | – | 3.1% | 3.1% | 6.4% | 3.8% | 7.0% | 8.1% | 9.0% | 11.8% | 7.8% | |
| – | 1.1% | – | 0.1% | 0.4% | 0.4% | 0.2% | 0.3% | 0.3% | 0.4% | 0.3% | 0.5% | |
| – | 9.8% | – | 1.4% | 0.8% | 3.0% | 1.6% | 3.4% | 3.3% | 1.8% | 4.6% | 2.6% | |
| – | -330.3% | – | -48.5% | -55.1% | -70.5% | 96.0% | 92.8% | 91.9% | 91.0% | 88.2% | 91.8% | |
| – | -358.2% | – | -52.0% | -59.2% | -75.3% | -43.1% | -55.6% | -73.8% | -98.9% | -139.5% | -186.5% | |
| – | 203.0% | – | 24.5% | 25.5% | 28.0% | 13.8% | 14.7% | 16.3% | 18.6% | 22.1% | 26.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.